APO Research
Talk to an analyst

APO RESEARCH · REPORT

Extracorporeal Shock Wave Lithotripsy (ESWL)

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital.

Selected research

Market Analysis & Forecast

Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Analysis and Forecast 2026-2032

2 January 2026204 pages

Choose your research edition.

Industry ResearchExtracorporeal Shock Wave Lithotripsy (ESWL) Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Extracorporeal Shock Wave Lithotripsy (ESWL) Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital.

The major players in global Extracorporeal Shock Wave Lithotripsy (ESWL) market include WIKKON, Hyde, Sody, etc. The top 3 players occupy about 30% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 75% of the global market. B-ultrasound ESWL is the main type, with a share about 70%. Kidney Stone is the main application, which holds a share about 65%.

Report Includes

Read the full market overview

This report presents an overview of global market for Extracorporeal Shock Wave Lithotripsy (ESWL), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Extracorporeal Shock Wave Lithotripsy (ESWL), also provides the revenue of main regions and countries. Of the upcoming market potential for Extracorporeal Shock Wave Lithotripsy (ESWL), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Extracorporeal Shock Wave Lithotripsy (ESWL) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Extracorporeal Shock Wave Lithotripsy (ESWL) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Extracorporeal Shock Wave Lithotripsy (ESWL) revenue, projected growth trends, production technology, application and end-user industry.

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Company

WIKKON

HYDE

Sody

Haibin

Comermy

Dornier

Richard-Wolf

MTS

DirexGroup

Siemens

EDAP TMS

Storz Medical

Medispec

ELMED

EMD

US

Allengers

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Type

B-ultrasound ESWL

X-ray ESWL

X-ray & B-ultrasound ESWL

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Application

Kidney Stone

Biliary Calculi

Salivary Stones

Pancreatic Stones

Others

Extracorporeal Shock Wave Lithotripsy (ESWL) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extracorporeal Shock Wave Lithotripsy (ESWL) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Extracorporeal Shock Wave Lithotripsy (ESWL) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extracorporeal Shock Wave Lithotripsy (ESWL).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Extracorporeal Shock Wave Lithotripsy (ESWL) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Extracorporeal Shock Wave Lithotripsy (ESWL) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Extracorporeal Shock Wave Lithotripsy (ESWL) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. B-ultrasound ESWL Major Player Table 3. X-ray ESWL Major Player Table 4. X-ray & B-ultrasound ESWL Major Player Table 5. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Kidney Stone Major Player Table 7. Biliary Calculi Major Player Table 8. Salivary Stones Major Player Table 9. Pancreatic Stones Major Player Table 10. Others Major Player Table 11. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Trends Table 12. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Drivers Table 13. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Opportunities and Challenges Table 14. Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Restraints Table 15. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Share by Region (2021-2026) Table 18. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Share by Region (2027-2032) Table 20. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Players (2021-2026) Table 22. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Key Players Headquarters & Area Served Table 24. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Players, Product Type & Application Table 25. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Extracorporeal Shock Wave Lithotripsy (ESWL) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Type (2021-2026) Table 32. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Type (2027-2032) Table 33. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Application (2021-2026) Table 37. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Application (2027-2032) Table 38. WIKKON Company Information Table 39. WIKKON Business Overview Table 40. WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 42. WIKKON Recent Development Table 43. HYDE Company Information Table 44. HYDE Business Overview Table 45. HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 47. HYDE Recent Development Table 48. Sody Company Information Table 49. Sody Business Overview Table 50. Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 52. Sody Recent Development Table 53. Haibin Company Information Table 54. Haibin Business Overview Table 55. Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 57. Haibin Recent Development Table 58. Comermy Company Information Table 59. Comermy Business Overview Table 60. Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 62. Comermy Recent Development Table 63. Dornier Company Information Table 64. Dornier Business Overview Table 65. Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 67. Dornier Recent Development Table 68. Richard-Wolf Company Information Table 69. Richard-Wolf Business Overview Table 70. Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 72. Richard-Wolf Recent Development Table 73. MTS Company Information Table 74. MTS Business Overview Table 75. MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 77. MTS Recent Development Table 78. DirexGroup Company Information Table 79. DirexGroup Business Overview Table 80. DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 82. DirexGroup Recent Development Table 83. Siemens Company Information Table 84. Siemens Business Overview Table 85. Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 87. Siemens Recent Development Table 88. EDAP TMS Company Information Table 89. EDAP TMS Business Overview Table 90. EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 92. EDAP TMS Recent Development Table 93. Storz Medical Company Information Table 94. Storz Medical Business Overview Table 95. Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 97. Storz Medical Recent Development Table 98. Medispec Company Information Table 99. Medispec Business Overview Table 100. Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 102. Medispec Recent Development Table 103. ELMED Company Information Table 104. ELMED Business Overview Table 105. ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 107. ELMED Recent Development Table 108. EMD Company Information Table 109. EMD Business Overview Table 110. EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 112. EMD Recent Development Table 113. US Company Information Table 114. US Business Overview Table 115. US Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. US Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 117. US Recent Development Table 118. Allengers Company Information Table 119. Allengers Business Overview Table 120. Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio Table 122. Allengers Recent Development Table 123. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021-2026) & (US$ Million) Table 129. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (US$ Million) & (2027-2032) Table 130. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (US$ Million) & (2027-2032) Table 137. China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026) & (US$ Million) Table 138. China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032) & (US$ Million) Table 139. China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026) & (US$ Million) Table 140. China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Region (US$ Million) & (2021-2026) Table 147. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Region (US$ Million) & (2027-2032) Table 148. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026) & (US$ Million) Table 149. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032) & (US$ Million) Table 150. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026) & (US$ Million) Table 151. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032) & (US$ Million) Table 152. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021-2026) & (US$ Million) Table 154. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (US$ Million) & (2027-2032) Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Extracorporeal Shock Wave Lithotripsy (ESWL) Image Figure 2. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size Share 2021 VS 2025 VS 2032 Figure 4. B-ultrasound ESWL Image Figure 5. X-ray ESWL Image Figure 6. X-ray & B-ultrasound ESWL Image Figure 7. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Kidney Stone Image Figure 10. Biliary Calculi Image Figure 11. Salivary Stones Image Figure 12. Pancreatic Stones Image Figure 13. Others Image Figure 14. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size (US$ Million) & (2021-2032) Figure 15. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Type (2021-2032) Figure 22. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Application (2021-2032) Figure 25. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032) Figure 27. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032) Figure 28. North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Country (2021-2032) Figure 29. United States Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032) Figure 34. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032) Figure 35. Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Country (2021-2032) Figure 36. Germany Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032) Figure 46. China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032) Figure 47. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032) Figure 49. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032) Figure 50. Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Region (2021-2032) Figure 51. Japan Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032) Figure 59. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032) Figure 60. SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Country (2021-2032) Figure 61. Brazil Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • B-ultrasound ESWL
  • X-ray ESWL
  • X-ray & B-ultrasound ESWL
Applications
  • Kidney Stone
  • Biliary Calculi
  • Salivary Stones
  • Pancreatic Stones
  • Others
Companies covered
  • WIKKON
  • HYDE
  • Sody
  • Haibin
  • Comermy
  • Dornier
  • Richard-Wolf
  • MTS
  • DirexGroup
  • Siemens
  • EDAP TMS
  • Storz Medical
  • Medispec
  • ELMED
  • EMD
  • US
  • Allengers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Type
  3. 1.2.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 B-ultrasound ESWL
  5. 1.2.3 X-ray ESWL
  6. 1.2.4 X-ray & B-ultrasound ESWL
  7. 1.3 Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Application
  8. 1.3.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Kidney Stone
  10. 1.3.3 Biliary Calculi
  11. 1.3.4 Salivary Stones
  12. 1.3.5 Pancreatic Stones
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Extracorporeal Shock Wave Lithotripsy (ESWL) Market Dynamics
  1. 2.1 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Trends
  2. 2.2 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Drivers
  3. 2.3 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Opportunities and Challenges
  4. 2.4 Extracorporeal Shock Wave Lithotripsy (ESWL) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Perspective (2021-2032)
  2. 3.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Growth Trends by Region
  3. 3.2.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Region (2021-2026)
  5. 3.2.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Players
  2. 4.1.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Players (2021-2026)
  3. 4.1.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Key Players Headquarters & Area Served
  7. 4.4 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Players, Product Type & Application
  8. 4.5 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market CR5 and HHI
  11. 4.6.3 2025 Extracorporeal Shock Wave Lithotripsy (ESWL) Tier 1, Tier 2, and Tier 3
5 Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Type
  1. 5.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2032)
  3. 5.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Type (2021-2032)
6 Extracorporeal Shock Wave Lithotripsy (ESWL) Market Size by Application
  1. 6.1 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2032)
  3. 6.3 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 WIKKON
  2. 7.1.1 WIKKON Company Information
  3. 7.1.2 WIKKON Business Overview
  4. 7.1.3 WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 WIKKON Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  6. 7.1.5 WIKKON Recent Developments
  7. 7.2 HYDE
  8. 7.2.1 HYDE Company Information
  9. 7.2.2 HYDE Business Overview
  10. 7.2.3 HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 HYDE Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  12. 7.2.5 HYDE Recent Developments
  13. 7.3 Sody
  14. 7.3.1 Sody Company Information
  15. 7.3.2 Sody Business Overview
  16. 7.3.3 Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sody Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  18. 7.3.5 Sody Recent Developments
  19. 7.4 Haibin
  20. 7.4.1 Haibin Company Information
  21. 7.4.2 Haibin Business Overview
  22. 7.4.3 Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Haibin Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  24. 7.4.5 Haibin Recent Developments
  25. 7.5 Comermy
  26. 7.5.1 Comermy Company Information
  27. 7.5.2 Comermy Business Overview
  28. 7.5.3 Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Comermy Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  30. 7.5.5 Comermy Recent Developments
  31. 7.6 Dornier
  32. 7.6.1 Dornier Company Information
  33. 7.6.2 Dornier Business Overview
  34. 7.6.3 Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Dornier Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  36. 7.6.5 Dornier Recent Developments
  37. 7.7 Richard-Wolf
  38. 7.7.1 Richard-Wolf Company Information
  39. 7.7.2 Richard-Wolf Business Overview
  40. 7.7.3 Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Richard-Wolf Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  42. 7.7.5 Richard-Wolf Recent Developments
  43. 7.8 MTS
  44. 7.8.1 MTS Company Information
  45. 7.8.2 MTS Business Overview
  46. 7.8.3 MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MTS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  48. 7.8.5 MTS Recent Developments
  49. 7.9 DirexGroup
  50. 7.9.1 DirexGroup Company Information
  51. 7.9.2 DirexGroup Business Overview
  52. 7.9.3 DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 DirexGroup Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  54. 7.9.5 DirexGroup Recent Developments
  55. 7.10 Siemens
  56. 7.10.1 Siemens Company Information
  57. 7.10.2 Siemens Business Overview
  58. 7.10.3 Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Siemens Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  60. 7.10.5 Siemens Recent Developments
  61. 7.11 EDAP TMS
  62. 7.11.1 EDAP TMS Company Information
  63. 7.11.2 EDAP TMS Business Overview
  64. 7.11.3 EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  65. 7.11.4 EDAP TMS Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  66. 7.11.5 EDAP TMS Recent Developments
  67. 7.12 Storz Medical
  68. 7.12.1 Storz Medical Company Information
  69. 7.12.2 Storz Medical Business Overview
  70. 7.12.3 Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Storz Medical Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  72. 7.12.5 Storz Medical Recent Developments
  73. 7.13 Medispec
  74. 7.13.1 Medispec Company Information
  75. 7.13.2 Medispec Business Overview
  76. 7.13.3 Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Medispec Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  78. 7.13.5 Medispec Recent Developments
  79. 7.14 ELMED
  80. 7.14.1 ELMED Company Information
  81. 7.14.2 ELMED Business Overview
  82. 7.14.3 ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ELMED Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  84. 7.14.5 ELMED Recent Developments
  85. 7.15 EMD
  86. 7.15.1 EMD Company Information
  87. 7.15.2 EMD Business Overview
  88. 7.15.3 EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  89. 7.15.4 EMD Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  90. 7.15.5 EMD Recent Developments
  91. 7.16 US
  92. 7.16.1 US Company Information
  93. 7.16.2 US Business Overview
  94. 7.16.3 US Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  95. 7.16.4 US Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  96. 7.16.5 US Recent Developments
  97. 7.17 Allengers
  98. 7.17.1 Allengers Company Information
  99. 7.17.2 Allengers Business Overview
  100. 7.17.3 Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Allengers Extracorporeal Shock Wave Lithotripsy (ESWL) Product Portfolio
  102. 7.17.5 Allengers Recent Developments
8 North America
  1. 8.1 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (2021-2032)
  2. 8.2 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2032)
  3. 8.2.1 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026)
  4. 8.2.2 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032)
  5. 8.3 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032)
  6. 8.4 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2032)
  7. 8.4.1 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026)
  8. 8.4.2 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032)
  9. 8.5 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032)
  10. 8.6 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country
  11. 8.6.1 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021-2026)
  13. 8.6.3 North America Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (2021-2032)
  2. 9.2 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032)
  5. 9.3 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032)
  9. 9.5 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country
  11. 9.6.1 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (2021-2032)
  2. 10.2 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2032)
  3. 10.2.1 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026)
  4. 10.2.2 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032)
  5. 10.3 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032)
  6. 10.4 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2032)
  7. 10.4.1 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026)
  8. 10.4.2 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032)
  9. 10.5 China Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (2021-2032)
  2. 11.2 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032)
  5. 11.3 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032)
  9. 11.5 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country
  11. 11.6.1 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue (2021-2032)
  2. 12.2 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country
  11. 12.6.1 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Extracorporeal Shock Wave Lithotripsy (ESWL) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst